ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.
The Journal of Urology
◽
10.1097/ju.0000000000002238
◽
2021
◽
Author(s):
Patrick J. Hensley
◽
Ashish M. Kamat
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Clinical Trial Design
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Related Documents
Cited By
References
Contemporary Outcomes of Patients With Nonmuscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Letter.
The Journal of Urology
◽
10.1097/ju.0000000000002237
◽
2021
◽
Author(s):
Francesco Montorsi
◽
Marco Moschini
◽
Andrea Necchi
◽
Federico Deho
◽
Giorgio Gandaglia
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Clinical Trial Design
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop
Urology
◽
10.1016/j.urology.2013.10.030
◽
2014
◽
Vol 83
(2)
◽
pp. 262-265
◽
Cited By ~ 37
Author(s):
Jonathan P. Jarow
◽
Seth P. Lerner
◽
Paul G. Kluetz
◽
Ke Liu
◽
Rajeshwari Sridhara
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Drug Administration
◽
Trial Design
◽
Food And Drug Administration
◽
Clinical Trial Design
◽
Invasive Bladder Cancer
◽
New Therapies
◽
American Urological Association
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design
European Urology
◽
10.1016/j.eururo.2016.02.031
◽
2016
◽
Vol 70
(5)
◽
pp. 778-785
◽
Cited By ~ 18
Author(s):
Chinedu O. Mmeje
◽
Charles C. Guo
◽
Jay B. Shah
◽
Neema Navai
◽
H. Barton Grossman
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Clinical Trial Design
◽
Bacillus Calmette Guerin
Download Full-text
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
European Urology
◽
10.1016/j.eururo.2021.12.005
◽
2021
◽
Author(s):
Mathieu Roumiguié
◽
Ashish M. Kamat
◽
Trinity J. Bivalacqua
◽
Seth P. Lerner
◽
Wassim Kassouf
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Consensus Statement
◽
Clinical Trial Design
◽
Bacillus Calmette Guerin
◽
Group Consensus
◽
Muscle Invasive Bladder Cancer
◽
Cancer Group
◽
Muscle Invasive
Download Full-text
Re: Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design
The Journal of Urology
◽
10.1016/j.juro.2017.04.093
◽
2017
◽
Vol 198
(2)
◽
pp. 255-255
Author(s):
Sam S. Chang
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Clinical Trial Design
◽
Bacillus Calmette Guerin
Download Full-text
Re: Jarow JP et al.: Clinical Trial Design For the Development of New Therapies for Non–muscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop (Urology 2014;83:262-265)
Urology
◽
10.1016/j.urology.2014.03.034
◽
2014
◽
Vol 84
(2)
◽
pp. 494-495
◽
Cited By ~ 2
Author(s):
John Amrhein
◽
Ashish M. Kamat
◽
Alvaro Morales
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Drug Administration
◽
Trial Design
◽
Food And Drug Administration
◽
Clinical Trial Design
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
◽
American Urological Association
Download Full-text
Contemporary Outcomes of Patients with Non-Muscle Invasive Bladder Cancer Treated with BCG Therapy: Implications for Clinical Trial Design
The Journal of Urology
◽
10.1097/ju.0000000000001633
◽
2021
◽
Author(s):
Justin T. Matulay
◽
Roger Li
◽
Patrick J. Hensley
◽
Nathan A. Brooks
◽
Vikram M. Narayan
◽
...
Keyword(s):
Clinical Trial
◽
Bladder Cancer
◽
Trial Design
◽
Clinical Trial Design
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Bcg Therapy
◽
Muscle Invasive
Download Full-text
Faculty Opinions recommendation of Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.3246962.2931060
◽
2010
◽
Author(s):
Juan Palou Redorta
◽
Guillermo Urdaneta
Keyword(s):
Bladder Cancer
◽
Cancer Recurrence
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Scoring Model
◽
Bladder Cancer Recurrence
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Bacteria-Derived Alternatives to Live Mycobacterium bovis Bacillus Calmette–Guerin for Nonmuscle Invasive Bladder Cancer Treatment
Microbial Infections and Cancer Therapy
◽
10.1201/9781351041904-4
◽
2019
◽
pp. 123-188
Author(s):
Esther Julián
◽
Estela Noguera-Ortega
Keyword(s):
Bladder Cancer
◽
Cancer Treatment
◽
Mycobacterium Bovis
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guérin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison
Urology Annals
◽
10.4103/0974-7796.106873
◽
2013
◽
Vol 5
(1)
◽
pp. 7
◽
Cited By ~ 8
Author(s):
Teruo Inamoto
◽
Takanobu Ubai
◽
Takeshi Nishida
◽
Yutaka Fujisue
◽
Yoji Katsuoka
◽
...
Keyword(s):
Bladder Cancer
◽
Low Dose
◽
Invasive Bladder Cancer
◽
Bacillus Calmette Guerin
◽
Minimal Morbidity
◽
Prospective Comparison
◽
Comparable Effect
◽
Nonmuscle Invasive Bladder Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close